SemaThera (@Sema_Thera) header
SemaThera (@Sema_Thera) profile picture

Entreprise en démarrage développant des inhibiteurs de SEMA 3A - Startup company developing SEMA 3A inhibitors / Dr Mike Sapieha HMR, Montreal, Québec, Canada

Montreal, Quebec
Joined October 2016
Photo by SemaThera (@Sema_Thera)Photo by SemaThera (@Sema_Thera)
Mike Sapieha receives Cogan Award at ARVO 2019
2
3
10
Congrats to our COO, Mike Sapieha a newly elected fellow of the Royal Society of Canada. can-acn.org/congratulations-…
4
3
SemaThera retweeted
Delighted to share this news of Inversago Pharma! xitter.gq/NewsFromBW/status/1022…
Inversago Pharma Receives $7 Million in Series A Financing dlvr.it/Qcjf3p
3
7
Inversago Pharma Receives $7 Million in Series A Financing dlvr.it/Qcjf3p
Synthetic #cannabinoid #CB1 receptor blockers poised for a comeback after #Montreal based @inversago pharma announces $7M Series A funding. #T1D #PWS #Lifesciences businesswire.com/news/home/2….
3
4
Lumira Ventures portfolio company Antiva Biosciences completes $15 Million Series C-1 financing with Hillhouse Capital, Sirona Capital and existing investors including Canann, Sofinnova, Brace Pharma, Osage and Lumira - markets.businessinsider.com/…
SemaThera retweeted
"AI-enabled tools will quickly feel invisible, making way for a more personal doctor-to-patient experience. #AI can empower clinicians to do their best work by freeing up their attention to do what only a human can." Look into the future courtesy... newsroom.gehealthcare.com/be…
6
10
SemaThera retweeted
Second session: Study case of SpecificiT Pharma Inc. @PierreBeauparlant CEO of SpecificiT, Grazia Maion from @univalor, Alain Dumont from GGD, Ines Holzbaur @AmorChem
2
2
Thanks to Minister Barrette’s support xitter.gq/cqdm_canada/status/100…
Thanks to Minister Barrette for the announcement of our support to a $1.1M project to develop the main therapeutic antibodies for @iBiosolutions' against cancer #QcBIO2018 #BIO2018
4
4
13
Veronique Bougie from @corbin_thera doing a great job pitching at the @BIOTECanada dragon’s den!!
3
4
AMORCHEM ANNOUNCES AN INVESTMENT BY FONDACTION IN ITS FUND businesswire.com/news/home/2…
2
3
SEMA 3A was identified as a novel target for ocular diseasesthat promotes vascular leakage and contributes to diabetes-related macular edema. goo.gl/ZAGBUx #Diabetes #DME @Sema_Thera
2
3
SemaThera signed an agreement with Chiome for the exclusivity on the anti-SEMA 3A monoclonal antibody contents.xj-storage.jp/xcont…
3
3
SemaThera retweeted
Congrats Mike, and no shock to us, as we have been unraveling macrophage biology and the innate immune system's role in ocular, cardiovascular and respiratory inflammation for some time now, under the umbrellas of our @Mperia_thera and @eosinate_thera newcos! xitter.gq/SciImmunology/status/9…
Macrophages in fat tissue may help promote #healthy weight gain and safeguard against diseases like type 2 #diabetes, find @psapieha & @Umontreal scientists https://xitter.gq/t.co/VXjTAns8xz
1
2